In first, new Alzheimer's drug modestly slows progress of disease, researchers say
US, Japanese drugmakers announce results of full study, but remains unclear how much of a difference it may make to lives of those affected by the condition
Stay updated with breaking news from Ron Petersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US, Japanese drugmakers announce results of full study, but remains unclear how much of a difference it may make to lives of those affected by the condition
Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.
New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening. The next question is how much difference that might make in people's lives.
An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening -- but the anxiously awaited new data leaves unclear how much difference that might make in people's lives.
/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in...